BioSpace News Archive

Pharm Country

Madrigal Pharma Announces Proposed Public Offering of Common Stock

Madrigal Pharma today announced that it has commenced an underwritten public offering of $100M of its common stock.

December 18, 2017
·
3 min read
Drug Development

Aduro Biotech Announces the Initiation of a Phase I/II Clinical Trial of BION-1301, a Novel Anti-APRIL Antibody, for the Treatment of Multiple Myeloma

The study is designed to evaluate the safety and activity of BION-1301, a humanized anti-APRIL antibody, for adults with relapsed or refractory multiple myeloma.

December 18, 2017
·
7 min read
Drug Development

Catalyst Biosciences Announces Acceleration of Phase I/II Trial of CB 2679d/ISU304 in Individuals with Hemophilia B

Catalyst Biosciences today announces that the Korean MFDS has approved a protocol amendment to omit single dose Cohort 4 and move directly to multi-dose Cohort 5 at 150 IU/kg daily, in the ongoing Phase 1/2 multi-dose study of CB 2679d/ISU304, Catalyst’s highly potent next-generation coagulation Factor IX variant in individuals with severe hemophilia B.

December 18, 2017
·
4 min read
Business

Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2017

Zimmer Biomet announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2017.

December 18, 2017
·
1 min read
Deals

IntriCon Completes Acquisition of Hearing Help Express

Terms of the transaction include $650,000 in cash, repayment of approximately $1.83 million in debt to HHE’s 80-percent holder and an earn-out.

December 18, 2017
·
5 min read
Varex Sets Annual Meeting and Record Dates

Varex Imaging today announced it has established record and meeting dates for its 2018 Annual Meeting of Stockholders.

December 18, 2017
·
1 min read